Clinical trial
To Explore the Effect of Growth Hormone on Outcomes of in Vitro Fertilisation and Telomerase Activity of Granulosa Cells in Women With Poor Ovarian Response
NCT04384744 is registered in ClinicalTrials.gov with Guangzhou First People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Explore the Effect of Growth Hormone on Outcomes of in Vitro Fertilisation and Telomerase Activity of Granulosa Cells in Women With Poor Ovarian Response
- Lead sponsor
- Guangzhou First People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 26, 2020
- Completion date
- November 30, 2021
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
gh, poor ovarian reserve based on poseidon